JPH04173086A - Carrier for culturing animal cell - Google Patents
Carrier for culturing animal cellInfo
- Publication number
- JPH04173086A JPH04173086A JP2299891A JP29989190A JPH04173086A JP H04173086 A JPH04173086 A JP H04173086A JP 2299891 A JP2299891 A JP 2299891A JP 29989190 A JP29989190 A JP 29989190A JP H04173086 A JPH04173086 A JP H04173086A
- Authority
- JP
- Japan
- Prior art keywords
- carrier
- amino acid
- peptide
- cells
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、動物細胞を培養するために用いられる担体に
関するものである。一般に動物細胞を培養する目的で固
体に動物細胞を接着させ伸展させるには、動物の血清中
に含まれる細胞接着性蛋白質が必要となるが、本発明は
血清成分を用いることなく、動物細胞の固定化を可能に
する動物細胞培養用担体に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a carrier used for culturing animal cells. Generally, cell adhesion proteins contained in animal serum are required to adhere and spread animal cells on a solid surface for the purpose of culturing animal cells. The present invention relates to a carrier for culturing animal cells that enables immobilization.
生理活性物質を生産させる等の目的で動物細胞を大量培
養する場合、浮遊状態で増殖出来る一部の細胞を除き殆
んどの細胞は何等かの固体表面に接着しないと増殖する
ことが出来ない、そのために、細胞が接着出来る培養面
積を如何にして大きくし、その生産性を高めるかという
点に工夫が凝らされる。この様な工夫をせしめた培養用
の担体に多糖類やポリスチレンなどのポリマーがあり、
この担体を利用するマイクロキャリアー培養法は容積当
りの培養面積を最も大きく採ることが出来る方法の一つ
である。しかしながら、之等のポリマーには細胞を接着
・伸展させる充分な能力が無いため、ポリマーをコラー
ゲンでコーティングしたり化学的合成により正の電荷を
持たせる等の改良が行なわれて来た。コラーゲンは細胞
を接着させるアミノ酸配列を有しており、また担体の正
の荷電は細胞表面が負に荷電しているために電気的な吸
着現象が起こる。When culturing animal cells in large quantities for purposes such as producing physiologically active substances, most cells, with the exception of some cells that can grow in suspension, cannot grow unless they adhere to some kind of solid surface. For this reason, efforts are being made to find ways to increase the culture area on which cells can adhere and increase productivity. Polymers such as polysaccharides and polystyrene are used as culture carriers that have been devised in this way.
The microcarrier culture method using this carrier is one of the methods that allows the largest culture area per volume. However, since these polymers do not have sufficient ability to adhere and spread cells, improvements have been made such as coating the polymer with collagen or imparting a positive charge through chemical synthesis. Collagen has an amino acid sequence that allows cells to adhere to each other, and since the carrier is positively charged and the cell surface is negatively charged, an electrical adsorption phenomenon occurs.
動物細胞を固体表面に接着させ、且つ細胞が増殖出来る
状態である処の伸展状態にするために。To attach animal cells to a solid surface and to place them in a stretched state where they can proliferate.
−射的手法では血清を添加するが、この方法は細胞の接
着・伸展機能を活性化する血清中のフィブロネクチンや
ビトロネクチン等の細胞接着性蛋白質が必要となるから
である。- Serum is added in the injection method, but this method requires cell adhesion proteins such as fibronectin and vitronectin in serum that activate cell adhesion and spreading functions.
化学的合成により正の電荷を持たせたポリマーは細胞を
静電気的力で吸引するだけでは細胞が増殖態勢を採れる
細胞伸展状態には至らぬため、血清中の細胞接着性蛋白
質を添加して生物学的細胞接着状態を作る必要がある。Polymers that have been given a positive charge through chemical synthesis cannot reach a stretched state in which cells can proliferate simply by attracting cells with electrostatic force, so cell adhesion proteins in serum are added to the polymer to attract cells using electrostatic force. It is necessary to create a state of chemical cell adhesion.
一方、コラーゲンでコーティングしたポリマーはコラー
ゲンの細胞に対する生物親和性と蛋白質としてのコラー
ゲンが持つ正の電荷により、細胞に対する接着性を付与
しているが、コラーゲンが担体から剥離したり培養液中
に溶解して了うといった問題点が残る。コラーゲンを化
学的手法により架橋すればコラーゲンのポリマーからの
剥離や培養液中への溶解を避けることが出来るが、之に
は処理前のものと比べて生物親和性が劣るという欠点が
生じる。また、細胞接着性蛋白質の活性部位であるAr
g −Gly −Aspのアミノ酸配列を、コラーゲン
は持っているものの、コラーゲンの分子構造に起因する
立体的構造では、この活性部位が細胞のレセプター内に
存在する結合部位に直接届き難いため、その接着性活性
効果は低く、結果として血清の添加が必要となっている
のが現状である。On the other hand, collagen-coated polymers provide adhesive properties to cells due to collagen's biological affinity for cells and the positive charge of collagen as a protein, but collagen may peel off from the carrier or dissolve in the culture medium. The problem remains that the process is completed. Cross-linking collagen by chemical methods can avoid detachment of collagen from polymers and dissolution in culture medium, but this has the drawback of inferior biocompatibility compared to untreated collagen. In addition, Ar, which is the active site of cell adhesion protein,
Although collagen has the amino acid sequence g-Gly-Asp, the three-dimensional structure resulting from the molecular structure of collagen makes it difficult for this active site to directly reach the binding site within the cell receptor, resulting in its adhesion. At present, the sexual activation effect is low, and as a result, it is necessary to add serum.
細胞培養に血清を用いることには以下の様な問題点があ
る。The use of serum for cell culture has the following problems.
■培養用の血清は高価であり、−射的な培養法では培養
液の費用の約9割が血清式となる。(2) Serum for culture is expensive, and in the direct culture method, about 90% of the cost of the culture solution is serum-based.
■血清は原因不明のロット差があり、再現性の良い結果
を得られないことがある。■There are unexplained lot differences in serum, which may make it difficult to obtain reproducible results.
■血清は蛋白質などの多様な成分から成っているため、
細胞の生産した有用物質を培養液から精製するのが困難
である。■Since serum is composed of various components such as proteins,
It is difficult to purify useful substances produced by cells from culture fluid.
血清を用いない手段として、フィブロネクチンやビトロ
ネクチン等の細胞接着性蛋白質のみを添加するだけでも
細胞の接着・伸展は成る程度進行するが、血清から精製
して得られる細胞接着性蛋白質は、血清よりも遥かに高
価で大量培養への応用は現実的ではない。As a method that does not use serum, cell adhesion and spreading can proceed to a certain extent by adding only cell adhesion proteins such as fibronectin and vitronectin, but cell adhesion proteins obtained by purification from serum are more effective than serum. It is far more expensive and its application to mass culture is impractical.
上記の課題を解決するために本発明者等は以下の知見に
鑑み、その実用化を進めることによって本発明を完成す
るに至った。In order to solve the above-mentioned problems, the present inventors have completed the present invention by proceeding with the practical application in view of the following knowledge.
フィブロネクチン、ビトロネクチン、フィブリノーゲン
、ラミニン、コラーゲン等の蛋白質に共通するArg、
Gly、 Aspの3つのアミノ酸がN末端よりこの順
序でペプチド結合したArg −Gly −Aspのア
ミノ酸配列は細胞接着性蛋白質の活性部位であり、細胞
の接着・伸展機能を活性化する機能を持つ。つまり、細
胞には接着・伸展を制御するレセプターがあり、Arg
−Gly −Aspのアミノ酸配列がそのレセプター
内の結合部位に特異的に作用することにより、初めて細
胞は固体表面への接着を開始し、そして伸展する訳であ
る。よって、全く同様なアミノ酸配列を含む合成ペプチ
ドが何かの固体表面付近に存在すれば細胞接着性蛋白質
の存在しない培養液中でも細胞のレセプターは合成ペプ
チドと結合し、それによって活性化された細胞は、その
まま近接するポリマー表面に接着し伸展することが出来
る。Arg, which is common to proteins such as fibronectin, vitronectin, fibrinogen, laminin, and collagen,
The amino acid sequence Arg-Gly-Asp, in which three amino acids Gly and Asp are peptide-bonded in this order from the N-terminus, is the active site of a cell adhesion protein and has the function of activating cell adhesion and spreading functions. In other words, cells have receptors that control adhesion and spreading, and Arg
It is only when the amino acid sequence of -Gly-Asp acts specifically on the binding site within its receptor that cells begin to adhere to a solid surface and then spread. Therefore, if a synthetic peptide containing exactly the same amino acid sequence is present near a solid surface, cell receptors will bind to the synthetic peptide even in a culture medium without cell adhesion proteins, and the activated cells will be activated by this. , it can be directly attached to and stretched onto adjacent polymer surfaces.
この現象を動物細胞培養用担体に応用したのが本発明で
ある。その内容は、スペーサーと見立てた分子量3,0
00以上の高分子を親水性ポリマーに共有結合させ、そ
のスペーサーの末端にArg −Gly−Aspのアミ
ノ酸配列を含む合成ペプチドを共有結合させ、無血清培
地中でも細胞が担体に接着、伸展8来る動物細胞培養用
担体としたものである。The present invention applies this phenomenon to carriers for animal cell culture. The content is a spacer with a molecular weight of 3.0
00 or more is covalently bonded to a hydrophilic polymer, and a synthetic peptide containing the amino acid sequence of Arg-Gly-Asp is covalently bonded to the end of the spacer, allowing cells to adhere to the carrier and spread even in serum-free medium. It is used as a carrier for cell culture.
親水性ポリマーに合成ペプチドを共有結合させる際に介
入させるスペーサーは、Arg −Gly −Aspの
活性ペプチドがレセプター内の結合部位に結合し易いよ
うにするためと、結合した後に細胞がポリマーに対して
伸展し易い位置を採り得る様にするためのものである。The spacer that is inserted when covalently bonding a synthetic peptide to a hydrophilic polymer is used to make it easier for the active peptide of Arg-Gly-Asp to bind to the binding site within the receptor, and to make it easier for cells to bind to the polymer after binding. This is to make it possible to take a position where it is easy to extend.
之はレセプター内の結合部位が接着域から離れた細胞膜
上の奥まった所に存在しており、合成ペプチドの長さよ
りも接着域から結合部位までの距離の方が長いことに起
因している。つまり、ポリマーそのものは結合部位付近
に近付くことが出来ないため、合成ペプチドを直接ポリ
マーに共有結合させるだけでは合成ペプチドの活性部位
が結合部位に届かないし、仮りにレセプターに結合出来
たとしても細胞が充分に伸展出来るだけの立体的自由度
が奪われるため、結果として細胞の接着・伸展機能を高
めることが出来ないのである。この為、合成ペプチドと
ポリマーとの間にスペーサーを介入させる必要が生じる
訳である。This is because the binding site within the receptor is located deep on the cell membrane, away from the adhesive area, and the distance from the adhesive area to the binding site is longer than the length of the synthetic peptide. In other words, the polymer itself cannot get close to the binding site, so if you just covalently bond a synthetic peptide directly to the polymer, the active site of the synthetic peptide will not reach the binding site, and even if it were able to bind to the receptor, cells would not be able to reach the binding site. Since the steric degree of freedom that allows for sufficient stretching is taken away, the adhesion and spreading functions of cells cannot be enhanced as a result. For this reason, it becomes necessary to insert a spacer between the synthetic peptide and the polymer.
スペーサーにはポリエチレンイミン(1)を用いる。Polyethyleneimine (1) is used for the spacer.
(−C2H,−N(−C,H,−NH,)−C,H,−
NH−)n(1)ポリエチレンイミンは酸触媒の存在下
で重合させて得られ、その構造は高度に枝分かれした樹
枝状構造を有し、その性状がカチオン基を持った透明で
粘稠な水溶性ポリマーである。ポリエチレンイミンを本
発明のスペーサーに採用するのは以下の特徴により細胞
吸着性を向上することとスペーサー自身の培養液中への
溶出を防止出来ることによる。ペプチドが細胞のレセプ
ターに近付く為には取り敢えず細胞を担体に吸着させる
必要があるが、ポリエチレンイミンは現存する高分子素
材の中でも最もカチオン化密度が高いので静電気的引力
で細胞を吸着する能力があり、また水溶性の高分子であ
るので疎水的相互作用による細胞との反発が生じず、培
地中で細胞に容易に接触出来る。(-C2H,-N(-C,H,-NH,)-C,H,-
NH-)n(1) Polyethyleneimine is obtained by polymerization in the presence of an acid catalyst, and its structure has a highly branched dendritic structure, and its properties are clear and viscous water-soluble with cationic groups. Polymer. Polyethyleneimine is used as the spacer of the present invention because it improves cell adsorption due to the following characteristics and can prevent the spacer itself from being eluted into the culture medium. In order for peptides to approach cell receptors, it is necessary to first adsorb cells to a carrier, but polyethyleneimine has the highest cation density among existing polymer materials, so it has the ability to adsorb cells through electrostatic attraction. Moreover, since it is a water-soluble polymer, there is no repulsion with cells due to hydrophobic interaction, and it can easily come into contact with cells in the culture medium.
スペーサーとなる高分子が直鎖の場合、損傷を受けて分
子鎖が切断されると担体と結合していない方の一端が培
養液中へ溶出して了うが、枝分かれ構造を持つポリエチ
レンイミン分子は複数の末端基それぞれが担体に結合し
ているので遊離し難い構造となっている。If the spacer polymer is a straight chain, if the molecular chain is broken due to damage, the end that is not bound to the carrier will elute into the culture medium, but polyethyleneimine molecules with a branched structure has a structure that makes it difficult to release because each of its multiple terminal groups is bonded to a carrier.
このポリエチレンイミンの分子量は以下の理由により3
,000以上でなくてはならない。即ち。The molecular weight of this polyethyleneimine is 3 for the following reasons.
,000 or more. That is.
3.000未満になると分子の長さが短いため、合成ペ
プチドを直接ポリマーに結合させた場合と同様に、充分
な効果が得られないからである。This is because if it is less than 3.000, the length of the molecule will be short, and a sufficient effect will not be obtained, similar to when a synthetic peptide is directly bonded to a polymer.
本発明の支持体とする親木性ポリマーにはセルロースの
連続発泡体を用いる。この発泡体は、木材から作った高
純度パルプを化学処理したビスコースに少量の補強材と
気孔を形造る結晶物を加えて混合し金型に注入の上、加
熱後、冷却して凝固することにより得られる。この素材
を担体として選択した理由は、セルロースの表面が強い
親水性を示すため、水系で用いる限り支持体表面は水溶
液と同様に振る舞うことが出来るからである。An open cellulose foam is used as the wood-philic polymer used as the support of the present invention. This foam is made by mixing viscose, which is made by chemically treating high-purity pulp made from wood, with a small amount of reinforcing material and crystals that form pores, injecting it into a mold, heating it, and then cooling it to solidify. It can be obtained by This material was selected as a carrier because the surface of cellulose exhibits strong hydrophilicity, so as long as it is used in an aqueous system, the surface of the support can behave in the same way as an aqueous solution.
本発明に用いる合成ペプチドは、Arg、 Gly、A
spの3つのアミノ酸がN末端よりArg −Gly
−Aspの順序でペプチド結合したアミノ酸配列を含む
。The synthetic peptides used in the present invention include Arg, Gly, A
The three amino acids of sp are Arg-Gly from the N-terminus.
- Contains a peptide-bonded amino acid sequence in the order Asp.
オリゴペプチドまたはポリペプチドである。この合成ペ
プチドの一般式は下記の(2)、 (3)、 (4)。It is an oligopeptide or a polypeptide. The general formulas of this synthetic peptide are (2), (3), and (4) below.
(5)の何れかで表わせる。It can be expressed as either (5).
H−R1−Arg−Gly−Asp −R2−OH(2
)H−R,−Arg−Gly−Asp−OH(3)H−
Arg−Gly−Asp −R2−OH(4)H−Ar
g −Gly −Asp −OH(5)R工及びR2は
1個のアミノ酸残基、または複数のアミノ酸残基から成
るペプチド鎖である。アミノ酸の種類は特に限定しない
が、アミノ酸の立体配置は天然アミノ酸の立体配置と同
じL配置であることが好ましい、 Arg−Gly−A
sp以外のアミノ酸の結合順序は特に限定しない。合成
ペプチドの構成アミノ酸の総数は3個以上とする。H-R1-Arg-Gly-Asp-R2-OH(2
) H-R, -Arg-Gly-Asp-OH (3) H-
Arg-Gly-Asp-R2-OH(4)H-Ar
g -Gly -Asp -OH (5) R and R2 are peptide chains consisting of one amino acid residue or multiple amino acid residues. The type of amino acid is not particularly limited, but the configuration of the amino acid is preferably the L configuration, which is the same as the configuration of natural amino acids, Arg-Gly-A
The bonding order of amino acids other than sp is not particularly limited. The total number of amino acids constituting the synthetic peptide shall be 3 or more.
以下に、本発明による動物細胞培養用活性ペプチド付与
担体の1例として、実施例の若干を示すが、本発明は之
等の実施例に限定されるものではない。Some examples are shown below as examples of the active peptide-imparted carrier for culturing animal cells according to the present invention, but the present invention is not limited to these examples.
実施例1
1、ペプチドの合成
ペプチドの合成はMerrifieldの発案による固
相合成法により行なった。この合成法は有機溶媒に不溶
の支持体にアミノ酸を結合し、そこからペプチド鎖を延
長する方法である。合成にはアミノ酸はα−アミノ基を
Boa基で保護したBoa−アミノ酸を用い、有機溶媒
に不溶の支持体にはクロロメチル基を持つ1〜2%ジビ
ニルベンゼン架橋ポリスチレンを用いた。Example 1 1. Peptide synthesis The peptide was synthesized by the solid phase synthesis method proposed by Merrifield. This synthetic method involves binding amino acids to a support that is insoluble in organic solvents, and extending the peptide chain from there. In the synthesis, a Boa-amino acid with an α-amino group protected by a Boa group was used as the amino acid, and a 1-2% divinylbenzene crosslinked polystyrene having a chloromethyl group was used as a support insoluble in an organic solvent.
合成したペプチドは、ゲル濾過で粗精製後、高速液体ク
ロマトグラフィーを使用して精製し、(6)のペプチド
を得た。The synthesized peptide was roughly purified by gel filtration and then purified using high performance liquid chromatography to obtain peptide (6).
H−Gly−Arg−GLy−Asp−5ar−Guy
−DH(6)2、担体素材の準備
セルロースの連続発泡体は一辺の長さが1■のキュービ
ック状に裁断し、細胞培養に適した大きさにした。(酒
伊エンジニャリング製)3、スペーサーの準備
スペーサーには分子量10,000のポリエチレンイミ
ンを使用した。H-Gly-Arg-GLy-Asp-5ar-Guy
-DH(6)2, Preparation of carrier material The open cellulose foam was cut into a cubic shape with a side length of 1 inch to a size suitable for cell culture. (manufactured by Sakai Engineering) 3. Preparation of Spacer Polyethyleneimine with a molecular weight of 10,000 was used for the spacer.
4、活性ペプチド付与担体の合成
活性ペプチド付与担体は、ポリエチレンイミンを架橋剤
によってセルロース発泡体にグラフトさせた後、ペプチ
ドのα−カルボキシル基とポリエチレンイミンのアミノ
基をカップリング試薬で酸アミド結合させることによっ
て得た。反応は総べてDMFやDMS○等の極性有機溶
媒中で行なつた。4. Synthesis of active peptide-attached carrier The active peptide-attached carrier is produced by grafting polyethyleneimine onto cellulose foam using a crosslinking agent, and then linking the α-carboxyl group of the peptide and the amino group of polyethyleneimine with an acid amide bond using a coupling reagent. I got it by doing that. All reactions were carried out in polar organic solvents such as DMF and DMS○.
実施例2
(7)のペプチドを合成し、実施例1に従い同様のスペ
ーサーと担体素材を用いて合成を行ない、活性ペプチド
付与担体を得た。Example 2 The peptide (7) was synthesized, and the synthesis was carried out using the same spacer and carrier material as in Example 1 to obtain an active peptide-attached carrier.
H−Arg−Giy−Asp−OH(7)実施例3
一辺の長さが5■のキュービック状に裁断したセルロー
スの連続発泡体径を担体素材とし、実施例1に従い同様
のスペーサーとペプチドを用いて合成を行ない、活性ペ
プチド付与担体を得た。H-Arg-Giy-Asp-OH (7) Example 3 A cellulose open cell foam cut into cubic shapes with a side length of 5 cm was used as a carrier material, and the same spacer and peptide were used according to Example 1. Synthesis was carried out to obtain an active peptide-attached carrier.
実施例4
分子量3,000のポリエチレンイミンをスペーサーと
し、実施例1と同様の担体素材とペプチドを用いて合成
を行ない、活性ペプチド付与担体を得た。Example 4 Synthesis was carried out using polyethyleneimine having a molecular weight of 3,000 as a spacer and the same carrier material and peptide as in Example 1 to obtain an active peptide-attached carrier.
比較例1
アルカリ性にしたセルロースの連続発泡体を2−アミノ
エチル硫酸と反応させてアミノエチルセルロースの連続
発泡体とし、それに実施例1と同様な合成ペプチド(6
)をカップリング試薬で直接共有結合し、動物細胞培養
用担体とした。Comparative Example 1 An open cellulose foam made alkaline was reacted with 2-aminoethyl sulfate to obtain an open foam of aminoethyl cellulose, and a synthetic peptide similar to that in Example 1 (6
) was directly covalently bonded with a coupling reagent and used as a carrier for animal cell culture.
比較例2
架橋デキストランビーズの表面をコラーゲンで被覆した
ファルマシア製Cytodsx3を動物細胞培養用担体
とした。Comparative Example 2 Cytodsx3 manufactured by Pharmacia, in which the surface of cross-linked dextran beads was coated with collagen, was used as a carrier for animal cell culture.
比較例3
架橋デキストランビーズの表面をN、N−ジエチルアミ
ノエチルクロライド塩酸塩で置換したPfeifer
&Langen社製のIlormacallを動物細胞
培養用担体とした。Comparative Example 3 Pfeifer in which the surface of cross-linked dextran beads was substituted with N,N-diethylaminoethyl chloride hydrochloride
Ilormacall manufactured by & Langen was used as a carrier for animal cell culture.
具体的実施例
実施例1〜4及び比較例1〜3を動物細胞培養用担体と
して、5%ウシ胎児血清培地中及び無血清培地中で細胞
培養を行なった。培地細胞にはチャイニーズハムスター
卵巣細胞を使用し、培養液にはダルベツコMEM培地と
ハムF−12培地の1:1混合液を用いた。血清培養法
及び無血清培養法の詳しい手順を以下に示す。Specific Examples Cell culture was carried out in a 5% fetal bovine serum medium and a serum-free medium using Examples 1 to 4 and Comparative Examples 1 to 3 as carriers for animal cell culture. Chinese hamster ovary cells were used as the culture medium, and a 1:1 mixture of Dulbecco's MEM medium and Ham's F-12 medium was used as the culture medium. Detailed procedures for the serum culture method and serum-free culture method are shown below.
1、血清を用いる培養
(1) 250墓l容のBellco社製スピンナーフ
ラスコに担体を25■1加え、(、a34 、 N g
2 +を含まないリン酸緩衝液(以下P B S (−
)と記載) 1001111に湿潤して、121℃、3
0分の条件でオートクレーブを行なう。1. Culture using serum (1) Add 25 μl of carrier to a 250-liter Bellco spinner flask, and add (, a34, N g
2+-free phosphate buffer (hereinafter referred to as PBS (-
) 1001111, 121℃, 3
Carry out autoclaving for 0 minutes.
(2)PBS(−)を捨て、血清培地を200−入れ、
この操作を2回繰り返した後、37℃にて2時間攪拌す
る。(2) Discard PBS(-) and add serum medium 200-
After repeating this operation twice, the mixture was stirred at 37°C for 2 hours.
(3)培地を捨て、2 X 10’cells/ l1
llIの濃度で細胞を含む血清培地30mに担体を吸い
込ませる様に播種する。(3) Discard the medium and add 2 x 10'cells/l1
The carrier is seeded in 30 ml of serum medium containing cells at a concentration of llI in such a manner that the carrier is absorbed.
(4) 37℃にて2時間以上放置した後、250dま
で血清培地を入れ、50rpmの速度で37℃で攪拌培
養する。(4) After leaving at 37°C for 2 hours or more, add serum medium up to 250 d and culture with stirring at 37°C at a speed of 50 rpm.
2、無血清培養
上記項目1の血清培地を、血清は含まず、インスリン、
エタノールアミン、トランスフェリン。2. Serum-free culture The serum medium from item 1 above does not contain serum and contains insulin,
Ethanolamine, transferrin.
セレニウムなどの細胞増殖を促す物質を含む無血清培地
に置き換え同様な方法で培養を行う。Culture is performed in the same manner by replacing the cells with a serum-free medium containing substances that promote cell proliferation, such as selenium.
実施例結果
培養結果より算呂した細胞密度の最大値を第1表に示す
。Example Results Table 1 shows the maximum cell density determined from the culture results.
第1表の結果から明らかな様に、血清を添加した培地中
では、どの担体を用いても細胞の増殖が詔められたが、
無血清培地中では実施例1〜4に限り増殖が認められた
。比較例1〜3の担体の場合、何れも無血清培地中では
細胞増殖は確認出来なかった。As is clear from the results in Table 1, cells proliferated in the medium supplemented with serum, regardless of the carrier used.
Proliferation was observed only in Examples 1 to 4 in serum-free medium. In the case of the carriers of Comparative Examples 1 to 3, cell proliferation could not be confirmed in any serum-free medium.
第1表 細胞密度
(細胞個数/培養液量 cells/ml)〔発明の効
果〕
以上説明した様に本発明の動物細胞培養用担体はレセプ
ターの結合部位まで届く充分に長いスペーサーを伸ばし
ており、尚且つそのスペーサーの先に接着・伸展に関わ
るレセプターを制御する活性ペプチドを有しているので
、血清を含む培地中は勿論、無血清培地中でも担体上に
細胞を接着・伸展させることが出来、必要最/Jl限の
栄養素を与えさえすれば細胞を充分に増殖させることが
出来る。従って本発明の動物細胞培養用担体を使用すれ
ば、血清を用いない細胞培養が可能になり、血清の添加
を起因する種々の問題点の克服が実現出来る。Table 1 Cell density (number of cells/amount of culture solution cells/ml) [Effects of the invention] As explained above, the animal cell culture carrier of the present invention has a sufficiently long spacer extending to reach the binding site of the receptor. Furthermore, since the spacer has an active peptide that controls receptors involved in adhesion and spreading at the end of the spacer, cells can be attached and spread on the carrier not only in serum-containing medium but also in serum-free medium. Cells can be sufficiently proliferated by providing only the required amount of nutrients. Therefore, by using the carrier for animal cell culture of the present invention, cell culture without using serum becomes possible, and various problems caused by the addition of serum can be overcome.
特許出願人 酒伊エンジニャリング株式会社戴麟麦酒株
式会社
一Patent applicant: Sakai Engineering Co., Ltd. Dairin Beer Co., Ltd.
Claims (1)
〜10.0m^2/g、空隙率が97%以上、比重が1
.4〜1.7g/cm^3の3次元網目構造を持つセル
ロース製連続発泡体を粒子径0.5mm〜5.0mmの
サイズに裁断し、アルギニン(以下Argと記載)、グ
リシン(以下Glyと記載)、アスパラギン酸(以下A
spと記載)から成る細胞接着因子Arg−Gly−A
spのアミノ酸残基を含む合成ペプチドを、分子量3,
000以上のポリエチレンイミンを介入させて上記発泡
体に共有結合させた動物細胞培養用担体。1: Average pore diameter is 0.3 to 2.0 mm, specific surface area is 1.0
~10.0m^2/g, porosity is 97% or more, specific gravity is 1
.. A cellulose open foam with a three-dimensional network structure of 4 to 1.7 g/cm^3 was cut into particles with a particle diameter of 0.5 mm to 5.0 mm, and arginine (hereinafter referred to as Arg) and glycine (hereinafter referred to as Gly) were cut into pieces with a particle size of 0.5 mm to 5.0 mm. ), aspartic acid (hereinafter referred to as A
Arg-Gly-A, a cell adhesion factor consisting of
A synthetic peptide containing sp amino acid residues with a molecular weight of 3,
A carrier for animal cell culture, in which polyethyleneimine of 000 or more is interposed and covalently bonded to the above-mentioned foam.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2299891A JPH04173086A (en) | 1990-11-07 | 1990-11-07 | Carrier for culturing animal cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2299891A JPH04173086A (en) | 1990-11-07 | 1990-11-07 | Carrier for culturing animal cell |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04173086A true JPH04173086A (en) | 1992-06-19 |
Family
ID=17878186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2299891A Pending JPH04173086A (en) | 1990-11-07 | 1990-11-07 | Carrier for culturing animal cell |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04173086A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004049921A (en) * | 2002-07-19 | 2004-02-19 | Sanyo Chem Ind Ltd | Wound dressing |
| KR100443696B1 (en) * | 2001-06-13 | 2004-08-09 | 주식회사 한기실업 | Synthetic net-shaped volumetric carriers having regular open-porous structures for biological filters |
| WO2023106379A1 (en) * | 2021-12-08 | 2023-06-15 | 国立大学法人 東京大学 | Cellulose porous particles, and microcarrier for culture use which comprises same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62298763A (en) * | 1986-06-18 | 1987-12-25 | Olympus Optical Co Ltd | Immobilization of ligand on inorganic carrier |
| JPS6443530A (en) * | 1987-08-10 | 1989-02-15 | Asahi Chemical Ind | Porous cellulose particle and its production |
| JPH01309682A (en) * | 1988-06-03 | 1989-12-14 | Sanyo Chem Ind Ltd | Substrate for animal cell culture |
-
1990
- 1990-11-07 JP JP2299891A patent/JPH04173086A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62298763A (en) * | 1986-06-18 | 1987-12-25 | Olympus Optical Co Ltd | Immobilization of ligand on inorganic carrier |
| JPS6443530A (en) * | 1987-08-10 | 1989-02-15 | Asahi Chemical Ind | Porous cellulose particle and its production |
| JPH01309682A (en) * | 1988-06-03 | 1989-12-14 | Sanyo Chem Ind Ltd | Substrate for animal cell culture |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100443696B1 (en) * | 2001-06-13 | 2004-08-09 | 주식회사 한기실업 | Synthetic net-shaped volumetric carriers having regular open-porous structures for biological filters |
| JP2004049921A (en) * | 2002-07-19 | 2004-02-19 | Sanyo Chem Ind Ltd | Wound dressing |
| WO2023106379A1 (en) * | 2021-12-08 | 2023-06-15 | 国立大学法人 東京大学 | Cellulose porous particles, and microcarrier for culture use which comprises same |
| JPWO2023106379A1 (en) * | 2021-12-08 | 2023-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2361968B1 (en) | Synthetic polysaccharide microcarriers for culturing cells | |
| CN103619911B (en) | Cross-linked poly-E-lysine non-particulate support | |
| US9068182B2 (en) | Synthetic polysaccharide microcarriers for culturing cells | |
| US5512474A (en) | Cell culture support containing a cell adhesion factor and a positively-charged molecule | |
| CN101405384B (en) | Cell culture substrate, preparation method and uses | |
| US20120052579A1 (en) | Peptide-modified microcarriers for cell culture | |
| US9677047B2 (en) | High surface area substrate for cell culture | |
| AU2009243226B2 (en) | Product for cell culture | |
| EP1576148A2 (en) | Process for coating cell-culture support | |
| JPH04173086A (en) | Carrier for culturing animal cell | |
| RU2396342C1 (en) | Method of producing three-dimensional matrices for tissue-like structures from animal cells | |
| JP2007537983A (en) | Cell attachment to the surface | |
| JP2021153441A (en) | Cell culture carrier and cell culture method | |
| JPH0638730A (en) | Carrier for culturing animal cell | |
| Ayhan et al. | A potential cell affinity sorbent: Fibronectin carrying poly (EGDMA/HEMA) microbeads | |
| Ayhan et al. | Collagen immobilization onto P (EGDMA/HEMA) microbeads for cell affinity systems | |
| JP2018126134A (en) | Carrier for cell culture | |
| JP2010220611A (en) | Medium for subculture and method for producing cell | |
| AU2012311912B2 (en) | Cross-linked poly-e-lysine non-particulate support | |
| Horii et al. | Designer Self-Assembling Peptide Scaffolds for Tissue Engineering and Regenerative Medicine | |
| CN116635144A (en) | Chromatography matrix and its use for purifying fibronectin | |
| Ayhan et al. | Collagen and fibronectin carrying PHEMA microbeads as cell affinity sorbents |